Debiopharm Group SA, of Lausanne, Switzerland, licensed ex-Japan development and commercialization rights to cancer drug DACH-Platin Polymeric Micelle (Debio 0507/NC-4016) from Chiba, Japan-based NanoCarrier Co. Ltd.(Other News To Note)

Debiopharm Group SA, of Lausanne, Switzerland, licensed ex-Japan development and commercialization rights to cancer drug DACH-Platin Polymeric Micelle (Debio 0507/NC-4016) from Chiba, Japan-based NanoCarrier Co. Ltd. Debiopharm will provide DACH-platin starting material and pay NanoCarrier an up-front fee, milestone payments, manufacturing costs and royalties. NanoCarrier will pay …